Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Diastology and New Echo Technologies Summit

Cleveland Clinic

The Cleveland Clinic 14th Diastology and New Echo Technologies Summit: Featuring Heart Valve and Contrast Echo Mini-Symposium activity is now available in a variety of multimedia formats to meet your continuing education needs— DVD, MP4, audio CD, and MP3.


 
CREDITS Earn up to 18.75 AMA PRA Category 1 Credits
CE RELEASE May 1, 2011
CE EXPIRE August 31, 2013
 
Item No Media (Can't decide on a format?) Price Purchase
CAX765DD
Video - DVD & MP4: Includes 10 DVDs and 2 MP4 digital discs with carrying case, 1 CD-ROM syllabus, and CME information.
$995.00
CAX765CD
Audio - CD & MP3: Includes 20 audio CDs and 1 MP3 digital disc with carrying case, 1 CD-ROM syllabus, and CME information.
$895.00
CAX765AV
Combo VIDEO/AUDIO Package: Includes 10 DVDs and 2 MP4 digital discs plus 20 audio CDs and 1 MP3 digital disc with carrying case, 1 CD-ROM syllabus, and CME information.
$1,395.00
CAX765ZW
Additional User Package: Includes 1 CD-ROM syllabus and CME information (initial video and/or audio purchase required).
$250.00
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Rebecca Sims at 800-633-4743 x3039. For all other sales inquiries, call 1-800-633-4743.
 

Program Information


Diastology and New Echo Technologies Summit provides a unique opportunity for participants to view key opinion leaders and review updates in heart valve disease, diastology, new and emerging echo technologies, and contrast echocardiography.

The Summit is divided into four parts.

Heart Valve Disease is a state-of-the-art mini-symposium on new advances in valvular heart disease including epidemiology, clinical diagnostic approaches to mitral tricuspid and aortic regurgitation and aortic stenosis, as well as new approaches to valve repair including robotics and percutaneous and transcatheter techniques.

Diastology summit presents new advances in diastolic heart failure including new guidelines, epidemiology, clinical diagnostic approaches, effects of therapy for diastolic heart failure, and clinical trial results.

New Echo Technologies summit will highlight new and emerging applications in real time 3-D and 4-D echo, live 3-D TEE, 2-D strain, stress echo, cardiac resynchronization interventional echo, and appropriateness criteria.

Contrast Echocardiography is a state-of-the-art minisymposium on the basic principles of contrast echo, rest and stress LVO and EBD, myocardial perfusion, and new research applications. There also will be discussions of safety issues and clinical trials on pulmonary pressures.


 
 

Intended Audience


This activity is designed for cardiologists, cardiac surgeons, anesthesiologists, sonographers, nurses, cardiology fellows, and other health care professionals interested in heart valve disease, diastology, new echocardiographic technologies, and contrast echocardiography.
 
 

Topics & Speakers


HEART VALVE DISEASE
Heart Valve Disease Summit Session 1: Mitral and Tricuspid Valve Disease
  • Keynote Address: State-of-the-Art of Imaging
    in Valvular Heart Disease 2011: Guidelines,
    Strengths, and Weaknesses
    Linda D. Gillam, MD, FACC, FASE
  • Epidemiology of Mitral Valve Regurgitation:
    When Do We Intervene? Medicine or Surgery?
    Brian P. Griffin, MD, FACC
  • Quantification of Mitral Regurgitation:
    From Basics to Advanced Measurements
    Sherif F. Nagueh, MD, FACC, FASE
  • Ischemic/Functional Mitral Regurgitation:
    Mechanism, Treatment, and New Trials
    Linda D. Gillam, MD, FACC, FASE
  • Mitral Valve Surgery: Robotic Repair?
    Edward Savage, MD
  • Panel Discussion and Questions
Heart Valve Disease Summit Session 2: Aortic Valve Disease and Percutaneous and Transcatheter Techniques
  • Columbia University Perspective
    Linda D. Gillam, MD, FACC, FASE
  • Cleveland Clinic Perspective
    Brian P. Griffin, MD, FACC
  • Surgeon’s Perspective
    Edward Savage, MD
  • Panel Discussion and Questions
Workshop: Heart Valve Disease Cases
  • “Read-with-the-Experts” Session:
    Mitral Regurgitation
    Brian P. Griffin, MD, Coordinator
  • “Read-with-the-Experts” Session: 
    Prosthetic Valve Dysfunction
    Linda D. Gillam, MD, Prosthetic Valve Dysfunction
  • “Read-with-the-Experts” Session: Mitral Stenosis
    Juan Carlos Plana, MD
  • “Read-with-the-Experts” Session:
    Low Pressure Aortic Stenosis
    Craig R. Asher, MD
  • “Read-with-the-Experts” Session: Aortic Regurgitation
    Annitta J. Morehead, RDCS
  • “Read-with-the-Experts” Session: 
    Tricuspid Regurgitation
    Allan L. Klein, MD


DIASTOLOGY
Diastology Session 1: Epidemiology, Biology, Physiology, and Basic Doppler Assessment
  • Keynote Address: State-of-the-Art of Diastology
    2011: Guidelines, Strengths and Weaknesses
    Sherif F. Nagueh, MD, FACC, FASE
  • Epidemiology: What Diseases?
    How Do We Assess? Prognosis?
    Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
  • Biology, Physics, and Physiology of Diastolic Function:
    The Basics
    James D. Thomas, MD, FACC, FAHA, FESC, FASE
  • Echo Doppler Assessment of Diastolic Function: Mitral
    Inflow, Pulmonary Vein, Tissue Doppler Imaging, and
    Color M-mode Doppler; Which One Do We Use
    in Clinical Practice?
    Sherif F. Nagueh, MD, FACC, FASE
Diastology Session 2: Practical Techniques, Filling Pressures, and New Tools
  • Performing a Diastolic Exam: Elements Required
    for Assessing the Left Ventricle
    Annitta J. Morehead, BA, RDCS, CCRC, FASE
  • Estimation of LV Filling Pressures Using Current
    Diastology Tools: Pearls and Pitfalls
    Juan Carlos Plana, MD, FACC
  • New Advances in the Assessment of Diastolic Function
    Using Strain and 2-D Strain: Added Value?
    Theodore P. Abraham, MD, MBBS, FACC, FASE
Diastology Session 3: Diseases with Diastolic Dysfunction
  • Pericardial Diseases: Is It Constriction or Restriction? Role of Pericardial Enhancement
    by MRI
    Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
  • HCM: From Genetics to Myectomy — What’s New?
    Craig R. Asher, MD, FACC
  • Diastolic Evaluation in Coronary Artery Disease and
    Hypertension: Separating Fact from Fiction
    Theodore P. Abraham, MD, MBBS, FACC, FASE

Diastology Session 4: Therapy of Diastolic Function and Clinical Applications

  • Therapy of Diastolic Dysfunction: What Have We
    Learned from Clinical Trials?
    W. H. Wilson Tang, MD, FACC, FAHA
  • Implementing the New Diastology Guidelines:
    How Do We Manage the Clinical Setting? Pitfalls?
    Discrepant Data?
    Sherif F. Nagueh, MD, FACC, FASE
  • Panel Discussion and Questions
Workshop: Diastolic Function Exam Cases
  • “Read-with-the-Experts” Session:
    Hypertrophic Cardiomyopathy
    Craig R. Asher, MD, Coordinator
  • “Read-with-the-Experts” Session: Noncompaction
    Jacobo Kirsch, MD
  • “Read-with-the-Experts” Session:
    Hypertrophic Cardiomyopathy
    Craig R. Asher, MD, Coordinator
  • “Read-with-the-Experts” Session: Hypertension
    Linda D. Gillam, MD
  • “Read-with-the-Experts” Session:
    Constrictive Pericarditis
    Juan Carlos Plana, MD
  • “Read-with-the-Experts” Session: Aortic Stenosis
    Brian P. Griffin, MD
  • “Read-with-the-Experts” Session:
    Restrictive Cardiomyopathy
    James D. Thomas, MD
Implications of Hand Held Ultrasound Systems
  • Welcome and Introduction
    Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
  • Hand Held Ultrasound Systems – Chicago Perspective
    Roberto M. Lang, MD, FACC, FASE
  • Hand Held Ultrasound Systems — Oregon Perspective
    Kevin S. Wei, MD, FACC
  • Role of Hand Held Ultrasound Systems in
    Screening Athletes
    Craig R. Asher, MD, FACC
  • Panel Discussion and Questions


NEW ECHOCARDIOGRAPHY TECHNOLOGIES
New Echocardiography Technologies Session 1: 3-D Echo and Real-Time TEE
  • Assessment of LV Function with 3-D:
    Strengths and Weaknesses
    Roberto M. Lang, MD, FACC, FASE
  • 3-D and 4-D Echo: Clinical Applications?
    Work Flow Implications
    James D. Thomas, MD, FACC, FAHA, FESC, FASE
  • Real-Time Transesophageal 3D Echocardiography:
    Incremental Value Over 2-D
    Roberto M. Lang, MD, FACC, FASE
  • Performing a 3-D Echo Examination: A Practical
    Approach for Sonographers
    Deborah A. Agler, RCT, RDCS, FASE
New Echocardiography Technologies Session 2: 2-D Strain
  • 2-D Strain for Cardiac Function: Clinical Use?
    Does It Have Prognostic Value?
    Juan Carlos Plana, MD, FACC
  • Tips and Techniques for Collecting Quality
    Strain Data
    Annitta J. Morehead, BA, RDCS, CCRC, FASE
  • Role of Echo in Cardiac Resynchronization: What Is the
    Current Indication? Future?
    Theodore P. Abraham, MD, MBBS, FACC, FASE
  • The Sonographer’s Role in CRT – Easy as One,
    Two, Three
    Deborah A. Agler, RCT, RDCS, FASE
New Echocardiography Technologies Session 3: Stress Echo, Atrial Fibrillation, Interventional Echo,
and Appropriateness Criteria
  • Stress Echocardiography: Should We Use Strain
    Daily to Assess Wall Motion? Diastology Stress Test?
    Theodore P. Abraham, MD, MBBS, FACC, FASE
  • Role of Echo in Atrial Fibrillation: Does It Have a
    Role in PV Ablation and LAA Closure?
    Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
  • Echo Guidance of Structural Heart Disease Interventions
    Linda D. Gillam, MD, FACC, FASE
  • Echocardiography: How Do We Use
    Appropriateness Criteria?
    Roberto M. Lang, MD, FACC, FASE
  • Panel Discussion and Questions
Workshop: New Echo Technologies: 3-D, CRT and Strain, TEE and Stress Echo, Atrial Fibrillation
“Read-with-the-Experts” Session
  • Strain in Stress Echo
    Juan Carlos Plana, MD, Coordinator,
  • 3-D TEE
    Linda D. Gillam, MD
  • Strain
    Sherif F. Nagueh, MD
  • Atrial Fibrillation
    Allan L. Klein, MD
  • Percutaneous Valve Repair
    Brian P. Griffin, MD
  • CRT Responder and Nonresponder
    Theodore P. Abraham, MD
  • New Contrast Applications
    Kevin S. Wei, MD


CONTRAST ECHOCARDIOGRAPHY
Contrast Echocardiography Session 1: Contrast Basics, Physics, and Imaging Modalities
  • Keynote Address: State-of-the-Art of Contrast Echo
    2011: Safety Issues, Strengths, and Weaknesses
    Sharon L. Mulvagh, MD, FACC, FASE
  • Contrast Physics 101: What Happens When You Combine Contrast Agents and Ultrasound?
    Kevin S. Wei, MD, FACC
  • Bring Value and Improvement to Your Echo Exam:
    A Step-by-Step Guide to Collecting LVO Images
    Annitta J. Morehead, BA, RDCS, CCRC, FASE
Contrast Echocardiography Session 2: Left Ventricular Opacification and Perfusion
  • Clinical Decision Making Using Contrast Echo:
    Rest and Stress Echo and ICU
    Sharon L. Mulvagh, MD, FACC, FASE
  • 3-D Contrast Echo: Can It Be Done?
    What Does It Add?
    Roberto M. Lang, MD, FACC, FASE
  • How to Read Myocardial Perfusion:
    How Do You Do It?
    Should We Be Doing This Routinely?
    Kevin S. Wei, MD, FACC
Workshop: “Read-with-the-Experts”
  • LVO and Stress Perfusion Cases
    Kevin S. Wei, MD, Coordinator, Contrast Echo in ER
    Allan L. Klein, MD, LAA Opacification
    Sharon L. Mulvagh, MD, Perfusion Cases Rest and Stress
    Sherif F. Nagueh, MD, Rest or Stress Echo LVO
    Juan Carlos Plana, MD, Rest or Stress Echo LVO
    James D. Thomas, MD, Rest or Stress Echo LVO
 
Contrast Echocardiography Session 3: Clinical Trials and New Research Developments
  • Recent Clinical Trials on Contrast Echo:
    Effects of Contrast on Pulmonary Hemodynamics
    Sharon L. Mulvagh, MD, FACC, FASE
  • New Research Developments in Contrast Echo:
    Targeted Microbubbles, Vasovasorum Imaging
    Kevin S. Wei, MD, FACC
  • Panel Discussion and Questions


 
 

Learning Objectives


After viewing this activity, the participant will be able to do the following for each session:
Heart Valve
  • Describe state-of-the-art imaging in valvular heart disease;
  • Summarize the epidemiology, quantification, and
    treatment strategies for both mitral and aortic regurgitation;
  • Discuss surgical mitral valve repair including
    robotic surgery;
  • Describe controversies in the management of
    aortic stenosis;
  • Describe percutaneous and transcatheter approaches
    to mitral and aortic diseases.
Diastology
  • Describe the epidemiology, biology, and physiology
    of diastolic function;
  • Discuss the role of various echo Doppler approaches
    to diastolic function assessment;
  • Estimate left ventricular filling pressures using
    current diastology tools;
  • Describe practical techniques for performing a
    diastolic examination and interpreting results;
  • Diagnose diseases with impaired diastolic function
    including pericardial diseases, cardiomyopathy, coronary
    artery disease, hypertrophic obstructive cardiomyopathy,
    hypertension, and pressure overload;
  • Highlight clinical trials results and describe future trials;
  • Discuss new ASE diastology guidelines.
New Echocardiography Technologies
  • Discuss the clinical role of 3-D and 4-D echocardiography
    in the assessment of cardiac function;
  • Summarize advances in real-time TEE imaging;
  • Discuss the role of strain in assessing cardiac function
    and CRT;
  • Describe the clinical practice role of stress
    echocardiography in atrial fibrillation;
  • Provide practical tips to acquire 3-D, strain, CRT images;
  • Discuss echo guidance of structural heart interventions;
  • Summarize the role of appropriateness criteria for echo.
Contrast Echocardiography
  • Assess the safety, strengths, and weaknesses of current contrast echocardiography technologies;
  • Explain the basics of contrast echocardiography,
    including the contrast and ultrasound interaction;
  • Describe the step-by-step approach to performing
    left ventricular opacification;
  • Summarize the role of contrast echo in clinical
    decision making;
  • Describe the role of contrast echo with stress echo
    and 3-D echo;
  • Interpret results from EBD, LVO, and
    myocardial perfusion;
  • Discuss new research developments and clinical trials
    with contrast echocardiography.

 
 

Accreditation


The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
 

Designation


The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Date of original release: May 1, 2011
Date of credit termination: August 31, 2013

CME credit is obtained upon successful completion of an activity posttest and evaluation, as well as payment of a $30 processing fee.